Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban… - Annals of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
[引用][C] Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban… - Annals of the …, 2023 - hwmaint.ard.bmj.com
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
B Molina, R Padoan, ML Urban, P Novikov… - Annals of the …, 2023 - europepmc.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban… - Annals of the …, 2023 - search.proquest.com
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban, P Novikov… - ANNALS OF THE …, 2023 - flore.unifi.it
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban… - Annals of the …, 2023 - cris.maastrichtuniversity.nl
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban, P Novikov… - Annals of the …, 2023 - ard.bmj.com
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B Molina, R Padoan, ML Urban… - Annals of the …, 2023 - search.proquest.com
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is often associated with
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …
glucocorticoid-dependent asthma and/or ear, nose and throat (ENT) manifestations. When …